回收型支架联合动脉灌注化疗治疗晚期食管癌近期疗效观察及并发症分析

目的探讨回收型支架联合动脉灌注化疗治疗晚期食管癌伴严重吞咽困难患者疗效和临床应用价值。方法 54例晚期食管癌伴重度吞咽困难患者,在透视下行食管内支架置入,支架术后3～5 d在胃镜下取出支架。支架术后1周行导管动脉灌注化疗术。结果 54例晚期食管癌患者总有效率为87%（47/54）。食管支架置入后出现轻度胸痛25例,反酸、烧心10例,打嗝4例,无致死性并发症。结论回收型支架联合动脉灌注化疗治疗晚期食管癌疗效显著,并发症少,较传统食管支架置入安全有效。

Recovery esophageal stent combined with arterial infusion chemotherapy in the treatment of advanced esophageal carcinoma and its complications

Objective To investigate the clinical application value of recovery esophageal stent combined with arterial infusion chemotherapy for the treatment of advanced esophageal carcinoma patients with severe dysphagia. Methods 54 cases of advanced esophageal carcinoma patients with severe dysphagia, in the perspective of downlink esophageal stents, stent after 3～5 days in endoscopic stent removal. 1 week after stent implantation transcatheter arterial infusion chemotherapy. Results The total effective rate for 54 cases of patients with advanced esophageal cancer was 87%（47/54）. Esophageal stent in 25 cases with chest pain, 10 cases of acid regurgitation, heartburn, 4 cases of hiccup, no fatal complications. Conclusion The curative effect of recovery esophageal stent combined with arterial infusion chemotherapy in the treatment of advanced esophageal cancer significantly, fewer complications, compared with traditional esophageal stent implantation is safe and effective.